Randomized Controlled Trial to Compare Two Anti-scorpion Serums

L

Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.

Status and phase

Completed
Phase 4

Conditions

Scorpion Sting

Treatments

Biological: serum antiscorpion

Study type

Interventional

Funder types

Other

Identifiers

NCT00739440
Birmex-01-2008

Details and patient eligibility

About

The purpose of this study is to compare the efficiency and safety of the treatment against sting scorpion, using two serums, one elaborated by Birmex versus other commercial serum

Full description

We consider relevant conduct this study because the poisoning scorpion bite represents a public health problem. This is a randomized clinical trial, which included 120 subjects of both sexes aged 15 and 60 years old and residents of the state of Guanajuato, divided into 2 groups: 60 patients received antiscorpion serum of Birmex and 60 patients receive other commercial serum.

Enrollment

120 patients

Sex

All

Ages

15 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Sting scorpion
  • Informed consent
  • Age 15-60
  • Either sex
  • Resident in study area

Exclusion criteria

  • Previous treatment with gammaglobulin
  • Blood transfusion at any stage of life
  • Sensitivity or intolerance to serums antiscorpion or horse products
  • Pregnancy
  • Some immunodeficiency

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

120 participants in 2 patient groups

I
Experimental group
Description:
Patients 15 to 60 years with scorpion sting, will receive serum antiscorpion elaborated by Birmex
Treatment:
Biological: serum antiscorpion
II
Experimental group
Description:
Patients 15 to 60 years with scorpion sting, will receive other commercial serum antiscorpion (Alacramyn)
Treatment:
Biological: serum antiscorpion

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems